HCV therapy and risk of liver cancer recurrence: who to treat?
Nat Rev Gastroenterol Hepatol
.
2018 Jul;15(7):392-393.
doi: 10.1038/s41575-018-0018-5.
Epub 2018 May 11.
Authors
Massimo Colombo
1
2
,
Vincenzo Boccaccio
3
Affiliations
1
Center for Translational Research in Hepatology, Humanitas hospital and Humanitas Clinical and Research Center, Rozzano, Italy. mcolombo46@yahoo.it.
2
Department of Medicine, Humanitas hospital and Humanitas Clinical and Research Center, Rozzano, Italy. mcolombo46@yahoo.it.
3
Department of Medicine, Humanitas hospital and Humanitas Clinical and Research Center, Rozzano, Italy.
PMID:
29752455
DOI:
10.1038/s41575-018-0018-5
No abstract available
Publication types
Comment
MeSH terms
Adult
Antiviral Agents*
Carcinoma, Hepatocellular*
Hepatitis C*
Humans
Liver Neoplasms*
Liver Transplantation*
Neoplasm Recurrence, Local
Substances
Antiviral Agents